All the Active Ingredient Drugs
Lansoprazole 30 mg. Gatro res. caps. 28 X 30 mg
1-2 caps/day for adults and adolesc. aged 12-17
Tmt. of duodenal and gastric ulcer/Tmt. of reflux oesophagitis/
Prophyl. of reflux oesophagitis/ Eradic. of H. pylori concurr. given with antibiotic ther. for tmt. of H.pylori-assoc. ulcers/
Tmt. of NSAID-assoc. benign gastric and duodenal ulcers in pts. req.continued NSAID tmt./
Prophyl. of NSAID-assoc. gastric ulcers and duodenal ulcers in pts. at risk req. continued ther/ Symptom. gastroesophageal reflux dis./
Zollinger-Ellison syndr.
C/I: Hypersens. Concom. use with rilpivirine
PPI. Lansoprazole 15 mg, 30 mg. CAPS: 28. Duod. ulc: 30 mg 1 x dly for 4
wks. Maint: To prevent relapse: 15 mg 1 x
dly. Benign gastric. ulc: 30 mg 1 x dly for 8
wks. GERD: 30 mg 1 x dly for 4 wks. If
needed, 4 wks more. Maint: 15-30 mg.
GERD: 30 mg (or 15 mg in some
individuals) 1 x dly for 4 wks. If not
alleviated, further investigations
recommended. Maint: 15 mg 1 x dly. Erad.
H. pylori: 30 mg 2 x dly with antibiotics as
in med. lit. Zollinger Ellison synd./other
hypersecretory cond: 2 x 30 mg 1 x dly.
Adjust per individual as long as necess. Up
to 180 mg dly have been used. If the req.
dly dose is greater than 120 mg, div. into 2
dly doses. NSAID-assoc. benign gastric
ulc., duod. ulc., relief sympts. in cont.
NSAID tmt: 15-30 mg 1 x dly for 4 wks. If
necess. 4 wks more. Pts at risk or with
refract. ulc., longer tmt. and/or poss.
higher dose. Elderly: No adjust. reqd.
Pediatric: No experience.
Duod. ulc., benign gastric ulc., GERD,
erad. H. pylori; Zollinger Ellison synd/
other hypersecretory conds, NSAIDassoc.
benign gastric ulc., duod. ulc.,
relief sympts. in cont. NSAID tmt.
C/I: Pregn..
